Xenetic Biosciences, Inc. (XBIO) › Operating IncomeXenetic Biosciences, Inc. (XBIO) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2012: -$6.34M2013: -$8.61M2014: -$12.92M2015: -$9.82M2016: -$47.43M2017: -$3.57M2018: -$7.28M2019: -$12.89M2020: -$13.94M2021: -$5.75M2022: -$6.72M2023: -$4.52M2024: -$4.20M2025: -$2.83M-$2.83M2012Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$2.83M+32.6%2024-$4.20M+6.9%2023-$4.52M+32.8%2022-$6.72M-16.9%2021-$5.75M+58.8%2020-$13.94M-8.2%2019-$12.89M-77.1%2018-$7.28M-103.9%2017-$3.57M+92.5%2016-$47.43M-382.9%2015-$9.82M+24.0%2014-$12.92M-50.1%2013-$8.61M-35.8%2012-$6.34M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share